Advances in cellular therapy: 6th international symposium on the clinical use of cellular products, March 24 and 25, 2011, Erlangen, Germany
Advances in cellular therapy: 6th international symposium on the clinical use of cellular products, March 24 and 25, 2011, Erlangen, Germany
复制标题
细胞疗法的进展：第六届细胞产品临床应用国际研讨会，2011 年 3 月 24 日至 25 日，德国埃尔兰根
DOI：
10.1007/s00262-011-1190-4
复制
发表时间：
2012
期刊：
影响因子：
--
通讯作者：
Gerbitz A
中科院分区：
文献类型：
--
作者：
Ullrich E;Bosch J;Aigner M;Voelkl S;Kroeger I;Hoffmann P;Kreutz M;Dudziak D;Gerbitz A
“细胞疗法2011”：第六届细胞产品临床应用国际研讨会于2011年3月24日至25日在德国的埃尔兰根举行。12年前，该会议首次在里根斯堡举行，最初由安德烈亚斯·马肯森发起。在过去的几年里，它赢得了声誉，并吸引了来自世界各地的该领域的领先研究人员。今年的会议由埃尔兰根大学血液学与肿瘤学系（Andreas Mackensen）、皮肤病学系（格罗尔德舒勒）、埃尔兰根和里根斯堡血液学与肿瘤学系（Reinhard Andreesen）联合举办。原则上，“细胞治疗会议”旨在为基础和临床研究人员提供一个多学科的论坛，以便从不同的角度交流和了解细胞治疗的广泛范围。为期两天的会议约有400名国际与会者参加，包括免疫效应细胞（T细胞和NK细胞），调节细胞（Treg和MSC），抗原呈递细胞，癌症疫苗接种，基因细胞治疗，代谢以及细胞治疗的监管问题和临床应用等领域的会议。23位受邀的国际专家在讲座中介绍了这些主题。此外，会上还介绍了从最高科学质量的摘要中选出的20个简短演讲和近130张海报。在本报告中，我们总结了最重要的研究成果，并强调了全体会议的主要讨论议题。
‘‘Cellular Therapy 2011’’: The 6th International Symposium on the Clinical Use of Cellular Products was held in Erlangen, Germany, on March 24–25, 2011. Twelve years ago, the conference took place for the first time in Regensburg and was originally initiated by Andreas Mackensen. Over the past years, it gained reputation and attracted leading researchers in the field from all over the world. This year’s conference was jointly organized at the University of Erlangen by the Department of Hematology & Oncology (Andreas Mackensen), the Department of Dermatology (Gerold Schuler), Erlangen, and the Department of Hematology & Oncology, Regensburg (Reinhard Andreesen). In principal, the ‘‘Cellular Therapy Meeting’’aims at providing a multidisciplinary forum for basic and clinical researchers to communicate and to learn about the broad scope of cell therapy from different perspectives. The two-day meeting was attended by approximately 400 international participants and included sessions in the field of immune effector cells (T cells and NK cells), regulatory cells (Treg and MSC), antigen-presenting cells, cancer vaccination, gene-based cellular therapy, metabolism as well as regulatory issues and clinical applications of cellular therapy. These topics were presented by talks from 23 invited international experts. In addition, 20 short talks selected from abstracts of highest scientific quality and almost 130 posters were presented at the meeting. In this report, we summarize the most important research findings and highlight the main discussion topics of the plenary sessions.